Assessing the Impact of Diabetes on Health and UK Population

This report investigates the impact of diabetes in the United Kingdom, focusing on its effects on health and the broader population. The introduction defines diabetes as a metabolic disease characterized by high blood sugar and explores its causes, including issues with insulin production and genetic or environmental factors. The methodology involves secondary research to gather data on diabetes's effects, including associated costs and complications. The results section details the complications of diabetes, its impact on morbidity and mortality, and the significance of glycemic control in managing the disease, referencing trials like the DCCT and UGDP. The report also analyzes the effectiveness of various treatments, including glucose-lowering drugs and blood pressure control measures. The conclusion emphasizes the importance of universal healthcare accessibility for effective diabetes management, referencing the UKPDS study. References to books and journals support the findings on diabetes-related issues.

The impact of diabetes
assessment criteria- health
and global population

Table of Contents
Title..................................................................................................................................................1
INTRODUCTION...........................................................................................................................1
Hypothesis........................................................................................................................................1
Methods............................................................................................................................................1
Results..............................................................................................................................................1
CONCLUSION and discussion.......................................................................................................3
REFERENCES................................................................................................................................4

Title
Impact of Diabetes in the United Kingdom.
INTRODUCTION
Diabetes is commonly known as a metabolic disease that has caused high blood sugar as
in this hormone insulin moves and transferred to move sugar from blood as into the cells that is
furthermore used to store energy. In this the body might not form enough insulin either don't
make effective insulin in the body (Heller and et. al., 2019). It is usually get occur when immune
system of body get fight with infections, destroy and attack beta cells that is insulin producing
with pancreas. It also caused genes in environmental factors such as virus which might have
occur trigger towards disease. The report below is dependent over impact of diabetes in UK
people.
Hypothesis
In this better knowledge and impact of diabetes is analyse that has affected life of UK
people's.
Methods
In order to conduct and collect appropriate knowledge and information as about the
impact of diabetes on people with support of secondary research as with this authentic level of
information is collected through which modified amount of outcome is achieved with perfection.
In relation to secondary research suitable information about relative topic within timely frame. In
this the associated cost as per concern of diabetes complications 5102 UKPDS patients are
diagnose and its mean age in 52.4 years (Graz and et. al., 2018). The cost of in and out patient
must have uses mutilple regression that is related to cost of admission multiplied with average
cost of speciality.
Results
The diabetes is a metabolic disorder that is primarily caused as per elevated level of
blood glucose by cardiovascular and microvascular under which substantial complications is
enhanced that is also be associated with morbidity and mortality as it also get reduces the quality
of life. It is also be characterised as per concern of total reliance towards exogenous insulin that
is comprised with support of survival as it cause 10% of diabetes. In this better amount will get
1

prevalent and it cause type 2 which is also be compromised with the 90% people as it is
characterised the deficiency of insulin as with this its resistance also get varied. As it is also get
associated in relation to varied range of complications that is elevated the level of blood glucose
as that is postulated the sustainability of body (Zang, Lynch, and West, 2020). It also get directly
links with the hyperglycemia along with its development and generation of complications of
diabetes. As per concern of its treatment glucose lowers and reduces the level of risk of
nephropathy, neuropathy and retinopathy. In terms of notable it is resultant into Diabetes control
and complications trial (DCCT) as with this level of similarity get designed under which
Stockholm intervention is developed. The type 1 of diabetes it lowers and reduces the glucose
level that also get delayed and slowed down the progression of microvascular complications. In
this the reduction of risk is caused the development of various outcomes that is ranged in
between 35-75%.
In relation to secondary analysis strong relationship risk in between complications
dealing and glycemic exposure over a certain period of time. Furthermore, there is no threshold
of discernible glucose as with this there is continuous level of reduction of glycemic level that is
also get approached normal range as with this improvised control of glycemic is associated that
also get reduces event of cardiovascular but its statistical factor doesn't have significant impact.
In relation to adequate studied it is found that most of young adults has a lesser rate (Hartmann-
Boyce and et. al., 2020). In support of type 2 diabetes it get correlate in between glycemic
control and a complication of diabetes and it is randomised three trail of complications that is
usually get attempted ordinate test that is beneficial to lower blood glucose that is related to
incident of complications. As per relation to University group diabetes program (UGDP) it
doesn't reflect any benefit of glycemic control HbA1c and in this only 200 subjects are included
and it is also be not reliable and relatable to measure chronic glycemia. The difference in
between glucose make supportive control that is highly intensive as it faster plasma glucose that
has major concern that emanate UGDP. It is observed biguanide (phenformin) and sulfonylurea
agent (tolbutamide) might get used in order to reduce hyperglycemia as it is also get directly
related to sustained increase of cardiovascular mortality.
The suspicion of glucose basically lower the oral agents that actually get harmed that also
get persist the control towards type 2 diabetes. In this patient get over for about an average of 10
years as to determine the intensive usage of pharmacological theraphy that also get reduced
2

adequate level of blood that is also get resulted into vital clinical benefits for example,
microvascular and cardiovascular complications. It is whether with the use of sulfonylurea drugs,
biguanide drugs, insuline, metformin that has offer specific advantage by therapeutic (Morrison,
and et. al., 2019). In relation to hypertensive randomised less or tight blood pressure get control
all the uncertainity that is also be beneficial towards lowering of blood pressure as with use of
ACE inhibitor (captopril) or β-blocker (atenolol) that get offered suitable benefits and
disadvantage to particular therapeutic. It get resulted into sustained increase of evident
hyperglycemia that is a major cause and contributor of complications. As per consideration of
epidemiological analysis of UKPD reflect that continuous relation is developed by which risk of
microvascular complication along with glycemia is decreased with the reduction of 35% of
complications.
CONCLUSION and discussion
It has been concluded from above report that all the individual that has associated with
healthcare program and system must have provide and offer universal accessibility that make
better control toward diabetes. It is discussed that as per result of UKPD it is resulted into
nephropathy, neuropathy and retinopathy that is always be beneficial to lower and reduces the
blood and glucose level as for type 2 level of diabetes intensive therapy is achieved and it is
7.0% in relation to conventional therapy as per its combination microvascular complications get
reduces with the rate of 25%.
3

REFERENCES
Books and Journals
Graz, H. and et. al., 2018. Diabetes-related amputations create considerable public health burden
in the UK. Diabetes research and clinical practice. 135. pp.158-165.
Hartmann-Boyce, J. and et. al., 2020. Diabetes and COVID-19: risks, management, and learnings
from other national disasters. Diabetes care. 43(8). pp.1695-1703.
Heller, S. and et. al., 2019. Towards a better understanding of postprandial hyperglycemic
episodes in people with diabetes: impact on daily functioning. Current medical research
and opinion. 35(3). pp.525-533.
Morrison, A. and et. al., 2019. Self-compassion, metabolic control and health status in
individuals with type 2 diabetes: a UK observational study.
Zang, E., Lynch, S.M. and West, J., 2020. Regional differences in the impact of diabetes on
population health in the USA. J Epidemiol Community Health.
4